Goodpoint Hotcongo this is why they need two seperate businesses. Getting vaccine opp developed going to cost 100s of millions only done via partnership otherwise the company would go bankrupt. For me it is laughable if ADAPT revenue will support that high full blown vaccine development, business only just about to breakeven with all new staff taken onboard.
AHZ is 2 companies -why not split into 2?, page-28
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.97 |
Change
-0.235(1.29%) |
Mkt cap ! $345.3M | |||
| Open | High | Low | Value | Volume |
| $18.09 | $18.09 | $17.88 | $1.182K | 66 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 60 | $17.88 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.05 | 554 | 1 |
View Market Depth
| Last trade - 14.30pm 10/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |